BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 11843691)

  • 1. Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain.
    Locatelli S; Lütjohann D; Schmidt HH; Otto C; Beisiegel U; von Bergmann K
    Arch Neurol; 2002 Feb; 59(2):213-6. PubMed ID: 11843691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism.
    Lütjohann D; von Bergmann K
    Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S102-6. PubMed ID: 14574622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.
    Vega GL; Weiner MF; Lipton AM; Von Bergmann K; Lutjohann D; Moore C; Svetlik D
    Arch Neurol; 2003 Apr; 60(4):510-5. PubMed ID: 12707064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.
    Serrano-Pozo A; Vega GL; Lütjohann D; Locascio JJ; Tennis MK; Deng A; Atri A; Hyman BT; Irizarry MC; Growdon JH
    Alzheimer Dis Assoc Disord; 2010; 24(3):220-6. PubMed ID: 20473136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients.
    Lütjohann D; Papassotiropoulos A; Björkhem I; Locatelli S; Bagli M; Oehring RD; Schlegel U; Jessen F; Rao ML; von Bergmann K; Heun R
    J Lipid Res; 2000 Feb; 41(2):195-8. PubMed ID: 10681402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
    Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
    Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Buschfort R; Ptok U; Björkhem I; von Bergmann K; Heun R
    J Psychiatr Res; 2002; 36(1):27-32. PubMed ID: 11755458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels.
    Thelen KM; Laaksonen R; Päivä H; Lehtimäki T; Lütjohann D
    J Clin Pharmacol; 2006 Jul; 46(7):812-6. PubMed ID: 16809807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls.
    Schönknecht P; Lütjohann D; Pantel J; Bardenheuer H; Hartmann T; von Bergmann K; Beyreuther K; Schröder J
    Neurosci Lett; 2002 May; 324(1):83-5. PubMed ID: 11983301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women.
    Vogelvang TE; Mijatovic V; van der Mooren MJ; Pinsdorf U; von Bergmann K; Netelenbos JC; Lütjohann D
    Maturitas; 2005 Apr; 50(4):312-20. PubMed ID: 15780532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 24S-hydroxycholesterol: a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease.
    Papassotiropoulos A; Lütjohann D; Bagli M; Locatelli S; Jessen F; Rao ML; Maier W; Björkhem I; von Bergmann K; Heun R
    Neuroreport; 2000 Jun; 11(9):1959-62. PubMed ID: 10884051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration.
    Del Puppo M; Galli Kienle M; Crosignani A; Petroni ML; Amati B; Zuin M; Podda M
    J Lipid Res; 2001 Mar; 42(3):437-41. PubMed ID: 11254756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease.
    Solomon A; Leoni V; Kivipelto M; Besga A; Oksengård AR; Julin P; Svensson L; Wahlund LO; Andreasen N; Winblad B; Soininen H; Björkhem I
    Neurosci Lett; 2009 Oct; 462(1):89-93. PubMed ID: 19560513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients.
    Kölsch H; Heun R; Kerksiek A; Bergmann KV; Maier W; Lütjohann D
    Neurosci Lett; 2004 Sep; 368(3):303-8. PubMed ID: 15364416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of 24S-hydroxycholesterol in men is not regulated by CYP7A1.
    Knabe C; Sudhop T; von Bergmann K; Lütjohann D
    Int J Clin Pharmacol Ther; 2007 Nov; 45(11):577-82. PubMed ID: 18077921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases.
    Bretillon L; Sidén A; Wahlund LO; Lütjohann D; Minthon L; Crisby M; Hillert J; Groth CG; Diczfalusy U; Björkhem I
    Neurosci Lett; 2000 Oct; 293(2):87-90. PubMed ID: 11027840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation.
    Björkhem I; Lütjohann D; Diczfalusy U; Ståhle L; Ahlborg G; Wahren J
    J Lipid Res; 1998 Aug; 39(8):1594-600. PubMed ID: 9717719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of 24S-hydroxycholesterol reflect the balance between cerebral production and hepatic metabolism and are inversely related to body surface.
    Bretillon L; Lütjohann D; Ståhle L; Widhe T; Bindl L; Eggertsen G; Diczfalusy U; Björkhem I
    J Lipid Res; 2000 May; 41(5):840-5. PubMed ID: 10787445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.
    Dias IHK; Milic I; Lip GYH; Devitt A; Polidori MC; Griffiths HR
    Redox Biol; 2018 Jun; 16():139-145. PubMed ID: 29501047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins.
    Höglund K; Wiklund O; Vanderstichele H; Eikenberg O; Vanmechelen E; Blennow K
    Arch Neurol; 2004 Mar; 61(3):333-7. PubMed ID: 15023808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.